{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-076578","form_type":"8-K","ticker":"CARM","cik":"0001485003","company_name":"Carisma Therapeutics Inc.","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.213676+00:00","generated_at":"2026-05-31T23:58:45.650426+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Carisma Therapeutics appoints Thorell and Scadden to board; Hodits and Odlander resign","bullets":["Regina Hodits and Björn Odlander resigned from board effective June 30, 2024, citing other professional commitments, not disagreements.","Marella Thorell and David Scadden elected as Class III directors, serving until 2026 annual meeting.","Thorell will chair audit committee; Scadden will chair science committee.","Each new director receives $40k annual cash retainer and option for 38,700 shares vesting monthly over 3 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-076578","json":"https://secwatch.observer/filing/0001104659-24-076578.json","markdown":"https://secwatch.observer/filing/0001104659-24-076578.md","text":"https://secwatch.observer/filing/0001104659-24-076578.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924076578/0001104659-24-076578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924076578/tm2418383d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:58:45.650426+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0feaee61bc","claim":"Regina Hodits resigned as Director at Carisma Therapeutics Inc..","evidence_excerpt":"On June 26, 2024, each of Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D. notified Carisma Therapeutics Inc. (the “Company”) of their respective decisions to resign from the Company’s board of directors, effective June 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924076578/0001104659-24-076578-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"56ae90ba44","claim":"Björn Odlander resigned as Director at Carisma Therapeutics Inc..","evidence_excerpt":"On June 26, 2024, each of Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D. notified Carisma Therapeutics Inc. (the “Company”) of their respective decisions to resign from the Company’s board of directors, effective June 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924076578/0001104659-24-076578-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"597f2bf1f0","claim":"Marella Thorell was elected as Director at Carisma Therapeutics Inc..","evidence_excerpt":"On June 26, 2024, the board of directors elected Marella Thorell and David Scadden, M.D. as directors of the Company, effective June 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924076578/0001104659-24-076578-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"dbdf99a923","claim":"David Scadden was elected as Director at Carisma Therapeutics Inc..","evidence_excerpt":"On June 26, 2024, the board of directors elected Marella Thorell and David Scadden, M.D. as directors of the Company, effective June 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924076578/0001104659-24-076578-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}